Indications for fetal echocardiography: consensus and controversies among evidence‐based national and international guidelines
Ultrasound in Obstetrics & Gynecology · 2025
DOI: 10.1002/uog.29224 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Ultrasound in Obstetrics & Gynecology, 2025. Verfasst von V De Robertis und 11 weiteren Autor:innen. Beteiligte Einrichtung: Fetal Medicine Unit, Di Venere Hospital, Bari, Italy. Hauptthemen laut MEDLINE: Echocardiography, Heart Defects, Congenital, Practice Guidelines as Topic, Ultrasonography, Prenatal. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 69 Literaturangaben.
Abstract (Originalsprache)
Objective
Fetal echocardiography (FE) is an indication‐driven examination for pregnant women with a fetus at high risk for congenital heart disease (CHD). Several familial, maternal and fetal factors are reported to increase the risk of CHD. The aim of this study was to highlight the existing differences in recommended indications for FE among recently published guidelines and consensuses of experts.
Methods
Guidelines and expert consensuses published from January 2008 to October 2023 were identified through a systematic literature search. FE guidelines and consensus statements were excluded if not written in the English language and if indications for FE were not reported. All familial, maternal and fetal risk factors for CHD reported in the consensuses and guidelines were listed and comparisons were made between documents. The agreement or disagreement for each risk factor between guidelines and consensuses was classified as: complete agreement (all analyzed documents reported the same indication); partial agreement (all documents considered a risk factor as an indication, but with inconsistency in its definition); or complete disagreement (inconsistency between documents for the considered risk factor as an indication).
Results
Six guidelines and expert consensuses that met the inclusion criteria were identified. Overall, a total of 17 risk factors were identified as an indication for FE. Complete agreement was reached for 3/17 (17.6%) risk factors, all of which are fetal risk factors (suspected CHD at the anomaly scan, presence of major fetal extracardiac abnormality and non‐immune hydrops fetalis). Partial agreement was recorded for 8/17 (47.1%) risk factors (family history of CHD, increased nuchal translucency, multiple gestation, maternal diabetes mellitus, maternal phenylketonuria, maternal infection, maternal autoimmune disease and autoantibody positivity, and teratogen exposure). Complete disagreement was recorded for 6/17 (35.3%) risk factors (inherited genetic disease associated with CHD, fetal genetic anomaly, suspected abnormality of heart rate or rhythm, first‐trimester sonographic markers of CHD, abnormality of umbilical cord and venous system, and use of assisted reproductive technology).
Conclusions
Areas of controversy regarding which CHD risk factors warrant FE were greater in quantity than were the areas of consensus. An internationally standardized agreement would be valuable for physicians and guideline developers. For many risk factors, further evidence is needed to justify their use as an indication for FE. © 2025 International Society of Ultrasound in Obstetrics and Gynecology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Fetal Medicine Unit, Di Venere Hospital, Bari, Italy.
- Unit of Fetal Medicine and Prenatal Diagnosis, Institute for Maternal and Child Health IRCCS Burlo Garofolo, Trieste, Italy.
- Department of Medicine, Surgery and Health Sciences, University of Trieste, Trieste, Italy.
- Department of Obstetrics and Gynecology, Eastern Virginia Medical School, Norfolk, VA, USA.
- Unit of Obstetrics and Gynecology, Department of Surgery, Dentistry, Pediatrics, and Gynecology, AOUI Verona, University of Verona, Verona, Italy.
- Center of Prenatal Diagnosis and Human Genetics, Berlin, Germany.
ORCID-Profile: V De Robertis, T Stampalija, M Bosco, R Chaoui, D Paladini
Zitieren
APA
De Robertis, V., Stampalija, T., Abuhamad, A. Z., Bosco, M., Chaoui, R., Formigoni, C., Moon-Grady, A. J., Paladini, D., Pilu, G., Ramezzana, I. G., Rychik, J., & Volpe, P. (2025). Indications for fetal echocardiography: consensus and controversies among evidence‐based national and international guidelines. Ultrasound in Obstetrics & Gynecology. https://doi.org/10.1002/uog.29224
Vancouver
De Robertis V, Stampalija T, Abuhamad AZ, Bosco M, Chaoui R, Formigoni C, et al. Indications for fetal echocardiography: consensus and controversies among evidence‐based national and international guidelines. Ultrasound in Obstetrics & Gynecology. 2025. doi:10.1002/uog.29224
BibTeX
@article{DeRobertis2025,
author = {De Robertis, V and Stampalija, T and Abuhamad, A Z and Bosco, M and Chaoui, R and Formigoni, C and Moon-Grady, A J and Paladini, D and Pilu, G and Ramezzana, I G and Rychik, J and Volpe, P},
title = {Indications for fetal echocardiography: consensus and controversies among evidence‐based national and international guidelines},
journal = {Ultrasound in Obstetrics & Gynecology},
year = {2025},
doi = {10.1002/uog.29224}
}
EUVIMED